These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20957039)

  • 1. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
    Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P
    PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells.
    Bachetti T; Di Zanni E; Ravazzolo R; Ceccherini I
    Biochim Biophys Acta; 2015 Aug; 1849(8):1057-65. PubMed ID: 26145533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
    Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
    Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma.
    Longo L; Borghini S; Schena F; Parodi S; Albino D; Bachetti T; Da Prato L; Truini M; Gambini C; Tonini GP; Ceccherini I; Perri P
    Int J Oncol; 2008 Nov; 33(5):985-91. PubMed ID: 18949361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
    de Pontual L; Trochet D; Bourdeaut F; Thomas S; Etchevers H; Chompret A; Minard V; Valteau D; Brugieres L; Munnich A; Delattre O; Lyonnet S; Janoueix-Lerosey I; Amiel J
    Eur J Cancer; 2007 Nov; 43(16):2366-72. PubMed ID: 17765533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.
    Di Paolo D; Yang D; Pastorino F; Emionite L; Cilli M; Daga A; Destafanis E; Di Fiore A; Piaggio F; Brignole C; Xu X; Liang C; Gibbons J; Ponzoni M; Perri P
    Oncotarget; 2015 Oct; 6(30):28774-89. PubMed ID: 26299615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHOX2B mutations and genetic predisposition to neuroblastoma.
    Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
    Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line.
    Di Lascio S; Saba E; Belperio D; Raimondi A; Lucchetti H; Fornasari D; Benfante R
    Exp Cell Res; 2016 Mar; 342(1):62-71. PubMed ID: 26902400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
    Trochet D; Bourdeaut F; Janoueix-Lerosey I; Deville A; de Pontual L; Schleiermacher G; Coze C; Philip N; Frébourg T; Munnich A; Lyonnet S; Delattre O; Amiel J
    Am J Hum Genet; 2004 Apr; 74(4):761-4. PubMed ID: 15024693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional characterization of the 5' upstream promoter of the human Phox2a gene: possible direct transactivation by transcription factor Phox2b.
    Hong SJ; Kim CH; Kim KS
    J Neurochem; 2001 Dec; 79(6):1225-36. PubMed ID: 11752063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma.
    Di Paolo D; Ambrogio C; Pastorino F; Brignole C; Martinengo C; Carosio R; Loi M; Pagnan G; Emionite L; Cilli M; Ribatti D; Allen TM; Chiarle R; Ponzoni M; Perri P
    Mol Ther; 2011 Dec; 19(12):2201-12. PubMed ID: 21829174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma.
    Raabe EH; Laudenslager M; Winter C; Wasserman N; Cole K; LaQuaglia M; Maris DJ; Mosse YP; Maris JM
    Oncogene; 2008 Jan; 27(4):469-76. PubMed ID: 17637745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons.
    Reiff T; Tsarovina K; Majdazari A; Schmidt M; del Pino I; Rohrer H
    J Neurosci; 2010 Jan; 30(3):905-15. PubMed ID: 20089899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations.
    McConville C; Reid S; Baskcomb L; Douglas J; Rahman N
    Am J Med Genet A; 2006 Jun; 140(12):1297-301. PubMed ID: 16691592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line.
    Yi B; Yang J; Wang L
    Tumour Biol; 2014 Apr; 35(4):3229-35. PubMed ID: 24293393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
    Borenäs M; Umapathy G; Lai WY; Lind DE; Witek B; Guan J; Mendoza-Garcia P; Masudi T; Claeys A; Chuang TP; El Wakil A; Arefin B; Fransson S; Koster J; Johansson M; Gaarder J; Van den Eynden J; Hallberg B; Palmer RH
    EMBO J; 2021 Feb; 40(3):e105784. PubMed ID: 33411331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines.
    Del Grosso F; De Mariano M; Passoni L; Luksch R; Tonini GP; Longo L
    BMC Cancer; 2011 Dec; 11():525. PubMed ID: 22192458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ALK as a major familial neuroblastoma predisposition gene.
    Mossé YP; Laudenslager M; Longo L; Cole KA; Wood A; Attiyeh EF; Laquaglia MJ; Sennett R; Lynch JE; Perri P; Laureys G; Speleman F; Kim C; Hou C; Hakonarson H; Torkamani A; Schork NJ; Brodeur GM; Tonini GP; Rappaport E; Devoto M; Maris JM
    Nature; 2008 Oct; 455(7215):930-5. PubMed ID: 18724359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.
    Di Paolo D; Brignole C; Pastorino F; Carosio R; Zorzoli A; Rossi M; Loi M; Pagnan G; Emionite L; Cilli M; Bruno S; Chiarle R; Allen TM; Ponzoni M; Perri P
    Mol Ther; 2011 Jun; 19(6):1131-40. PubMed ID: 21487394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.